Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Sustained release comfort formulation for glaucoma therapy|
|Abstract:||Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when indicated for control and lowering of intraocular pressure.|
|Inventor(s):||Jani; Rajni (Fort Worth, TX), Harris; Robert G. (Fort Worth, TX)|
|Assignee:||Alcon Laboratories, Inc. (Fort Worth, TX)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Use;|
|Country||Document Number||Publication Date|
|South Africa||8909204||Sep 26, 1990|
|World Intellectual Property Organization (WIPO)||9520378||Aug 03, 1995|
|United States of America||4911920||Mar 27, 1990|
|United States of America||5554367||Sep 10, 1996|
|Norway||963130||Jul 26, 1996|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.